En qué casos las determinaciones no son confiables | 02 ENE 19
Monitoreo del control glucémico
Qué hacer ante discordancias entre la glucemia y la hemoglobina glicosilada
37
28
Autor: Ravinder Sodi, Kim McKay, Srilatha Dampetla y colaboradores BMJ 2018;363:k4723
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1 Chamberlain JJ, Rhinehart AS, Shaefer CFJr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med 2016;164:542-52. 10.7326/M15-3016 26928912

2 Amiel SA, Pursey N, Higgins B, Dawoud DGuideline Development Group. Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance. BMJ 2015;351:h4188. 10.1136/bmj.h4188 26311706

3 Inzucchi SE. Clinical practice. Diagnosis of diabetes. N Engl J Med2012;367:54250.10.1056/NEJMcp1103643 22873534

4 Kilpatrick ES, Atkin SL. Using haemoglobin A(1c) to diagnose type 2 diabetes or to identify people at high risk of diabetes. BMJ 2014;348:g2867. 10.1136/bmj.g2867 247696585 Inzucchi SE, Bergenstal RM, Buse JB, etal. American Diabetes Association (ADA)European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)[Erratum in: Diabetes Care 2013;36:490]. Diabetes Care 2012;35:1364-79.10.2337/dc12-0413 22517736

6 Little RR, Sacks DB. HbA1c: how do we measure it and what does it mean?Curr Opin Endocrinol Diabetes Obes 2009;16:113-8. 10.1097/MED.0b013e328327728d 19300091

7 Sacks DB. Carbohydrates. In: Nader R, Horwarth AR, Wittwer CT, eds. Tietz textbook of clinical chemistry and molecular diagnostics. 6th Ed. Elsevier; 2017.

8 Little RR, La’ulu SL, Hanson SE, Rohlfing CL, Schmidt RL. Effects of 49 Different Rare Hb Variants on HbA1c Measurement in Eight Methods. J Diabetes Sci Technol 2015;9:849-56. 10.1177/1932296815572367 25691657 9 National Institute for Health and Care Excellence. Blood glucose management. 2015. https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations.10 Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8. 10.2337/diacare.25.2.275 11815495

11 McDonald TJ, Warren R. Diagnostic confusion? Repeat HbA1c for the diagnosis ofdiabetes. Diabetes Care 2014;37:e135-6. 10.2337/dc14-0055 24855169

12 Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol 2014;141:5-16. 10.1309/AJCPQ23GTTMLAEVL 24343732

13 Greene DN, Vaughn CP, Crews BO, Agarwal AM. Advances in detection of hemoglobinopathies. Clin Chim Acta 2015;439:50-7. 10.1016/j.cca.2014.10.006 25314938

14 Little RR, Rohlfing CL, Hanson S, etal . Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem 2008;54:1277-82. 10.1373/clinchem.2008.103580 18556332
15 Selvin E, Warren B, He X, Sacks DB, Saenger AK. Establishment of community-based reference intervals for fructosamine, glycated albumin  and1,5anhydroglucitol. ClinChem 2018;64:84350.10.1373/clinchem.2017.285742 29436378

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí